|
Name: Phenazocine
Type: Opioid
AKA: Narphen, Prinadol
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Phenazocine, a synthetic opioid analgesic, was first synthesized in the 1950s. It was developed for its analgesic properties and used in pain management. Its history reflects early advancements in opioid analgesics, with its use declining over time due to newer medications with improved safety profiles.
|
|
V. Legal Information
Phenazocine, an opioid analgesic, is classified as a controlled substance in many jurisdictions due to its potential for abuse. Its legal status varies by country, with regulations focused on its use in pain management and preventing misuse.
US Federal Schedule - II
Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence. These drugs are also considered dangerous. Some examples of Schedule II drugs are: combination products with less than 15 milligrams of hydrocodone per dosage unit (Vicodin), cocaine, methamphetamine, methadone, hydromorphone (Dilaudid), meperidine (Demerol), oxycodone (OxyContin), fentanyl, Dexedrine, Adderall, and Ritalin.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Phenazocine is an opioid used for pain relief. It acts as a downer, causing sedation and respiratory depression. Short-term use provides effective pain management, but long-term use can lead to addiction and tolerance. Overdose risks include severe respiratory depression and potential death. Safe use requires careful dosing and medical supervision. Recent research investigates its efficacy and safety compared to other opioids.  |
|
VII. Psychological Effects
Phenazocine, an opioid, impacts opioid receptors to produce analgesia and mood alteration. Immediate effects include euphoria and cognitive impairment, while long-term use may lead to dependence and psychological issues. Research examines its efficacy and potential for abuse.
 |
|
VIII. Culture
Phenazocine is an opioid analgesic, classifying it as a downer. Short-term use provides significant pain relief, while long-term use can lead to dependence, tolerance, and severe health issues. Overdose risks include severe respiratory depression and potential fatal outcomes. Safe dosages are typically prescribed by medical professionals. Recent research underscores its effectiveness in pain management but warns of its high abuse potential and associated risks. Physical effects include drowsiness, constricted pupils, and potential for respiratory depression.
 |